Home Blog Page 191

These Breast Cancer Facts Could Save Your Life

0

A nursing professor dispels common myths, explains the risks, and highlights promising new treatments. Breast cancer is one of the most commonly diagnosed cancers in the world and remains a major cause of cancer-related illness in the United States. A new case is identified in the U.S. roughly every two minutes, and in 2025 alone, […]

Source link

Karnataka government to train women who’ve taken career breaks in semiconductor industry

0

Visitors at the Bengaluru Tech Summit 2025 in Bengaluru on November 19, 2025.
| Photo Credit: SUDHAKARA JAIN

The Karnataka government will train 90 women in tier 2 and tier 3 cities in the State, who have taken sabbatical for various reasons, in VLSI design and embedded software, skills sought after by the semiconductor industry.

To take this effort forward, the Electronics Sector Skills Council (ESSCI), a State government outfit, has entered into an MoU with Marvell Marvell Semiconductor on Wednesday.

Minister for IT and BT Priyank Kharge said this training programme was mostly designed for women who have taken a career break and still want to get back to work after a sabbatical.

“We have always given top priority to skilling programmes to build a future-ready workforce. It is also our endeavour to help women who took career breaks to be industry-and technology-ready so that they can return to work,” Mr. Kharge said, while addressing a media conference at Bengaluru Technology Summit here on Wednesday.

The initiative supported Karnataka’s mission to boost women’s participation in deep-tech sectors. It also strengthens the State’s semiconductor talent pipeline in alignment with India’s growing chip ecosystem, he said.

Also, under the NIPUNA Karnataka, a State government initiative to skill over 4,000 youth in collaboration with leading corporate partners, the government has approved skill-development training by four skilling aggregators in partnership with potential employers including Capgemini, Wells Fargo, Standard Chartered, and Sumeru.

The NIPUNA was targeted for providing training in high-demand fields, including artificial intelligence, cybersecurity, and data science. Over 2,800 job opportunities were expected as part of this mission, the Minister said.

According to the Minister, the NIPUNA Karnataka is rapidly gaining national attention as a powerful collaborative model where corporates and skilling aggregators work hand-in-hand to shape the next generation workforce. This momentum has already encouraged several major employers across IT, ESDM, Biotech, and BFSI sectors to submit expressions of interest jointly with their skilling partners to skill an additional 10,000 youth, with the aspiration of enabling 7,000 more jobs across the State.

Source link

It’s Not Autism: The Real Tylenol Risk People Keep Overlooking

0

Each year, acetaminophen poisoning sends about 56,000 people to U.S. emergency rooms. A CU Anschutz Emergency Medicine toxicology specialist is exploring a new approach to treatment. As social media and news outlets circulate unverified claims about connections between acetaminophen use and autism in children, experts emphasize that the more immediate and well-documented issue is the […]

Source link

Help Us Investigate Medical Care for Gunshot Wounds

0

KFF Health News and The Trace are teaming up to take a deep look at how insurance status affects treatment for gunshot wounds. We’re looking for survivors, their friends and family, or family members of people who suffered complications or died from gunshot wounds after leaving the hospital. We want to hear about medical treatment, insurance coverage, and experiences after discharge from the hospital.

If you or someone you know has experienced the pain of a gunshot wound and you’re willing to talk about the medical experience, please fill out the form below. We’ll be in touch as soon as possible.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

Source link

A Glow-in-the-Gut Pill Could Make Colonoscopies Optional

0

Researchers designed microscopic hydrogel spheres filled with blood-detecting bacteria to identify gastrointestinal bleeding non-invasively. After being swallowed and passing through the body, the spheres can be magnetically collected and analyzed within minutes. In mice, the brightness of the bacterial glow revealed how severe colitis was. The technology could pave the way for easier gut-health diagnostics. […]

Source link

Google unveils Gemini’s next generation, aiming to turn its search engine into a ’thought partner’

0

Google is unleashing its Gemini 3 artificial intelligence model on its dominant search engine and other popular online services in the high-stakes battle to create technology that people can trust to enlighten them and manage tedious tasks.

The next-generation model unveiled Tuesday comes nearly two years after Google took the wraps off its first iteration of the technology. Google designed Gemini in response to a competitive threat posed by OpenAI’s ChatGPT that came out in late 2022, triggering the biggest technological shift since Apple released the iPhone in 2007.

Google’s latest AI features initially will be rolled out to Gemini Pro and Ultra subscribers in the United States before coming to a wider, global audience. Gemini 3’s advances include a new AI “thinking” feature within Google’s search engine that company executives believe will become an indispensable tool that will help make people more productive and creative.

“We like to think this will help anyone bring any idea to life,” Koray Kavukcuoglu, a Google executive overseeing Gemini’s technology, told reporters.

As AI models have become increasingly sophisticated, the advances have raised worries that the technology is more prone to behave in ways that jumble people’s feelings and thoughts while feeding them misleading information and fawning flattery. In some of the most egregious interactions, AI chatbots have faced accusations of becoming suicide coaches for emotionally vulnerable teenagers.

The various problems have spurred a flurry of negligence lawsuits against the makers of AI chatbots, although none have targeted Gemini yet.

Google executives believe they have built in guardrails that will prevent Gemini 3 from hallucinating or be deployed for sinister purposes such as hacking into websites and computing devices.

Gemini 3 ‘s responses are designed to be “smart, concise and direct, trading cliche and flatter for insight — telling you what you need to hear, not just what you want to hear. It acts as a true thought partner,” Kavukcuoglu and Demis Hassabis, CEO of Google’s DeepMind division, wrote in a blog post.

Besides providing consumers with more AI tools, Gemini 3 is also likely to be scrutinised as a barometer that investors may use to get a better sense about whether the massive torrent of spending on the technology will pay off.

After starting the year expecting to spend $75 billion, Google’s corporate parent Alphabet recently raised its capital expenditure budget from $91 billion to $93 billion, with most of the money earmarked for AI. Other Big Tech powerhouses such as Microsoft, Amazon and Facebook parent Meta Platforms are spending nearly as much — or even more — on their AI initiatives this year.

Investors so far have been mostly enthusiastic about the AI spending and the breakthroughs they have spawned, helping propel the values of Alphabet and its peers to new highs. Alphabet’s market value is now hovering around $3.4 trillion, more than doubling in value since the initial version of Gemini came out in late 2023. Alphabet’s shares edged up slightly Tuesday after the Gemni 3 news came out.

But the sky-high values also have amplified fears of a potential investment bubble that will eventually burst and drag down the entire stock market.

For now, AI technology is speeding ahead.

OpenAI released its fifth generation of the AI technology powering ChatGPT in August, around the same time the next version of Claude came out from Anthropic.

Like Gemini, both ChatGPT and Claude are capable of responding rapidly to conversational questions involving complex topics — a skill that has turned them into the equivalent of “answer engines” that could lessen people’s dependence on Google search.

Google quickly countered that threat by implanting Gemini’s technology into its search engine to begin creating detailed summaries called “AI Overviews” in 2023, and then introducing an even more conversational search tool called “AI mode” earlier this year.

Those innovations have prompted Google to de-emphasize the rankings of relevant websites in its search results — a shift that online publishers have complained is diminishing the visitor traffic that helps them finance their operations through digital ad sales.

The changes have been mostly successful for Google so far, with AI Overviews now being used by more than 2 billion people every month, according to the company. The Gemini app, by comparison, has about 650 million monthly users.

With the release of Gemini 3, the AI mode in Google’s search engine is also adding a new feature that will allow users to click on a “thinking” option in a tab that company executives promise will deliver even more in-depth answers than has been happening so far. Although the “thinking” choice in the search engine’s AI mode initially will only be offered to Gemini Pro and Ultra subscribers, the Mountain View, California, company plans to eventually make it available to all comers.

Published – November 19, 2025 09:08 am IST

Source link

Nvidia, Microsoft invest $15 billion in AI startup Anthropic

0

Nvidia and Microsoft announced Tuesday investments totaling $15 billion in AI startup Anthropic, creator of the Claude chatbot, amid frenzied spending on the technology and growing fears of a bubble.

AI chip powerhouse Nvidia committed up to $10 billion while Microsoft—which owns 27 percent of Anthropic rival OpenAI—pledged up to $5 billion to the maker of Claude AI models.

Microsoft also continues investing heavily in its own Copilot AI that runs on the company’s Azure platform.

The deal was part of a sweeping agreement that saw Anthropic commit to purchasing $30 billion in Microsoft’s cloud computing capacity and adopt the latest versions of Nvidia’s chip technology.

“We’re increasingly going to be customers of each other,” said Microsoft CEO Satya Nadella in an online video announcing the deal.

“We will use Anthropic models. They will use our infrastructure, and we’ll go to market together to help our customers realize the value of AI.”

The investments mark a significant realignment in the generative AI sector, where competition has intensified between ChatGPT-maker OpenAI and rivals including Anthropic, but also Google, which released its latest Gemini model on Tuesday.

California-based Anthropic was launched in 2021 by former OpenAI staff and positions itself as prioritizing safety in AI development. Its flagship product is the Claude chatbot and family of models.

Tech industry rivals, which also include Amazon, Meta and Elon Musk’s xAI, have been pouring tens of billions of dollars into artificial intelligence since the blockbuster launch of the first version of ChatGPT in late 2022.

Nvidia, meanwhile, has become a coveted source of high-performance GPUs tailored for generative AI.

With increasing talk among Wall Street analysts of an AI bubble, shares in Nvidia, the world’s biggest company by market capitalization, were down slightly amid a broad sell-off in the tech sector.

Microsoft’s shares were down about 2.5 percent.

Sources told CNBC that the fresh investment valued Anthropic at $350 billion, making it one of the world’s most valuable companies. OpenAI was most recently valued at $500 billion.

The massive investment in Anthropic comes a month after Nvidia announced it will pump as much as $100 billion into OpenAI, building infrastructure for future generations of the technology.

“Compute infrastructure will be the basis for the economy of the future,” OpenAI chief executive Sam Altman said at the time.

In a dizzying bout of deal-making, OpenAI also recently signed a $38 billion deal with Amazon’s AWS cloud computing arm, continuing a major partnership spree that has included Oracle, Broadcom and AMD.

Nvidia’s GPUs, originally designed for gaming systems, have become the essential building blocks of artificial intelligence applications, with tech giants scrambling to secure them for their data centers and AI projects.

Silicon Valley-based Nvidia also recently announced it would invest $5 billion in struggling chip rival Intel.

The investment, backed by the White House, represents a significant commitment to Intel’s turnaround efforts.

Published – November 19, 2025 09:36 am IST

Source link

Meta’s chief revenue officer John Hegeman leaves to launch startup

0

Clara Shih, who joined Meta last year to lead the business AI unit, is also leaving the company, according to Bloomberg News [File]
| Photo Credit: REUTERS

Meta’s chief revenue officer John Hegeman said on Tuesday he will leave the Facebook parent to launch his own startup, marking a key leadership change amid the social media company’s pursuit of superintelligence.

His key responsibilities will be taken over by another Meta executive, Andrew Bocking, who currently leads Meta’s ads product and strategy team, according to Hegeman’s Facebook post.

This comes after a Financial Times report last week that Meta’s chief AI scientist Yann LeCun is planning to leave the company to set up his own startup.

The company has been stepping up its investments in building AI infrastructure, with CEO Mark Zuckerberg reorganising the company’s AI initiatives under Superintelligence Labs.

Earlier this year, Zuckerberg hired Alexandr Wang, former CEO of data-labeling startup Scale AI, to lead the new AI effort.

Hegeman, citing “mix of emotions” regarding his departure, credited Zuckerberg for the trust and support.

Head of product at Meta, Naomi Gleit, will become the head of business AI, Hegeman said in his post.

Clara Shih, who joined Meta last year to lead the business AI unit, is also leaving the company, according to Bloomberg News.

Shih chose to step down from her position following her father’s unexpected death this year, according to the report.

Bloomberg News first reported Hegeman’s departure.

Meta did not immediately respond to a Reuters request for comment.

Source link

Microsoft Ignite 2025: Windows 11 push sparks debate over AI ambitions and OS stability

0

Copilot and a growing ecosystem of first- and third-party agents are set to become native fixtures of the Windows experience, promising streamlined workflows, enhanced productivity, and a more proactive system capable of autonomous support.
| Photo Credit: Special Arrangement

Microsoft’s Ignite 2025 announcements placed AI front and centre, positioning Windows 11 as a deeply agent-integrated platform. The company described the operating system as a canvas for intelligent automation, highlighting new agent infrastructure, direct connectors, and a dedicated workspace woven into familiar surfaces like the desktop and taskbar. 

Copilot and a growing ecosystem of first- and third-party agents are set to become native fixtures of the Windows experience, promising streamlined workflows, enhanced productivity, and a more proactive system capable of autonomous support.

But the promise of this AI-first future has collided with a wave of developer frustration. Many argue that the dramatic expansion of agentic features has arrived while core elements of Windows continue to feel unstable or underdeveloped. 

The long-standing critique that Windows 11 suffers from inconsistent UI design, persistent bugs, and performance degradation has only intensified as each major update shifts focus toward AI rather than fundamental refinement. Several users increasingly describe the OS as less friendly to those who rely on predictable behaviour, polished interfaces, and reliable tools.

Central to the controversy is Microsoft’s vision of an agentic operating system in which autonomous bots can access personal folders, operate in the background, and make decisions on the user’s behalf. Developers have voiced skepticism about the security model underpinning these features. 

Even Microsoft has warned of emerging risks such as cross-prompt injection attacks, where malicious content could manipulate an agent into exposing data or executing unintended actions. Although the company emphasises containment and safeguards, critics argue that granting such deep system access to autonomous processes exposes users to unprecedented privacy concerns.

Performance fears compound the backlash. Tests and early reports indicate that always-active agents may consume significant CPU and memory resources, potentially hampering responsiveness, especially on older hardware. For many, this raises uncomfortable parallels with the Windows 8 era, when radical redesigns alienated core users who valued stability over experimentation. The concern now is that the rapid pivot toward AI may outpace both ecosystem readiness and user trust.

Microsoft has acknowledged these criticisms, expressing regret that recent choices have diverged from community expectations. The company has pledged renewed attention to reliability, consistency, and performance in future updates, framing this moment as a necessary recalibration. 

The path ahead hinges on whether Microsoft can advance its agentic ambitions without compromising the foundational strengths that made Windows indispensable to developers and enterprises alike.

Source link

A Small Texas Think Tank Cultivated Covid Dissidents. Now They’re Running US Health Policy.

0

Martin Kulldorff, chair of the Trump administration’s reconstituted CDC vaccine panel, made a shocking — and misleading — statement as the group met in September. Referring to a clinical trial, Kulldorff, a biostatistician and former professor at Harvard Medical School, said eight babies born to women who received Pfizer’s covid vaccine while pregnant had birth defects, compared with two born to unvaccinated women.

“It is very concerning to have a fourfold excess risk of birth defects in these pregnant women,” Kulldorff then said.

Scientists criticized Kulldorff’s questions and remarks in that meeting because they suggested that the vaccine caused birth defects, which is not supported by evidence. The birth defects would have occurred before the women received the vaccine, the scientists said. They say it was one of several scientifically unsubstantiated claims by newly appointed members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, an influential panel that guides which vaccines millions of people receive and whether insurance covers their cost.

Many of the new panel members share a connection to a little-known think tank making its mark in President Donald Trump’s Washington: the Brownstone Institute.

Libertarian author Jeffrey Tucker created the nonprofit institute in 2021, fueled by backlash against covid lockdowns and other pandemic-era policies. “You cannot do something like that to the world and expect people just to sit by and go, ‘OK, that’s normal,’” Tucker said in an interview.

Tucker has endorsed child labor; said of covid shots that “there is no evidence at all that the vaccines saved millions,” contradicting numerous studies showing the opposite; and opposes vaccine mandates.

His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas-based think tank has received millions from donors whose identities are shielded in tax filings. And in recent months, its associates have catapulted to the highest levels of government.

At least eight people with ties to the Brownstone Institute hold or recently held senior positions at federal health agencies or key roles advising the government, exercising significant authority over access to vaccines and scientific research.

They include Jay Bhattacharya, director of the National Institutes of Health, which has been racked by funding cuts and firings under the Trump administration, as well as senior Food and Drug Administration officials Vinay Prasad and Tracy Beth Høeg. Prasad has been involved in restricting the use of covid vaccines. Høeg has voiced skepticism about vaccine mandates and some childhood immunizations.

Bhattacharya was a senior scholar for the organization. Brownstone has published Bhattacharya’s and Prasad’s writings on its website. Høeg has reported receiving payment from the group.

The institute has compensated Kulldorff and published his articles. Tucker wrote in October that 2020 marked “the beginning of a long friendship” with Kulldorff “that continues to this day.” Three other ACIP members share connections with the organization: MIT operations management professor Retsef Levi, who has spoken as part of at least one Brownstone event; physician Robert Malone, who speaks at its events and whose articles appear on its website; and Case Western Reserve University professor and epidemiologist Catherine Stein, who in 2022 authored an article calling for an end to vaccine mandates at universities.

Thomas Buckley, a public relations professional who wrote for the institute, accepted a political appointment as a top NIH spokesperson after thousands of workers at the biomedical research agency were fired. Buckley noted on Substack that his Brownstone writings “led to my new job.”

“That’s maybe his judgment,” Tucker said.

Buckley, when asked to elaborate, said in an email that he interviewed Bhattacharya “for a story that was later published on Brownstone — it was simply me being polite.” He said he resigned from the NIH on Sept. 30. NIH spokesperson Laci Williams declined to confirm his departure date.

Despite the ascendence of those with ties to his group, Tucker said that “anybody who thinks that somehow Brownstone is some big plot, it’s crazy.” He said he is not in regular contact with Health and Human Services Secretary Robert F. Kennedy Jr., whose department oversees the CDC, FDA, and NIH.

“I don’t have any influence,” Tucker said.

Sowing Vaccine Doubt

People with ties to the institute have sown doubt about covid vaccines or routine childhood immunizations, dismissing widespread evidence that they are safe and the benefits outweigh the risks.

“They’ve successfully placed their ideology inside the mechanism that determines U.S. vaccine policy,” said Jake Scott, a physician at Stanford Medicine who specializes in infectious diseases. “It’s very, very troubling.”

Tucker said that Brownstone “doesn’t have any operational impact on the ACIP committee at all” and that “if somebody wasn’t troubled by Brownstone, there’s probably no reason for us to exist.”

Tucker and Brownstone’s associates express libertarian views and promote distrust of government, including public health authorities.

“The evidence is mounting and indisputable that MRNA vaccines cause serious harm including death, especially among young people. We have to stop giving them immediately!” Levi posted on social media in 2023, referring to vaccines based on messenger RNA technology, which Pfizer-BioNTech and Moderna used to develop their covid shots. Stein wrote that covid vaccine mandates are “unethical” and not scientifically justified. Bhattacharya asserted on a podcast with Trump ally Stephen Bannon that mRNA technology for vaccines is “no longer viable,” and he has overseen mass terminations of NIH grants for scientific research.

Kennedy in June fired all 17 members of the CDC’s vaccine panel and has replaced them with 12 people so far, including individuals with connections to the Brownstone Institute. Tucker said that he did not propose to the White House or HHS that they be appointed and that Brownstone has not paid them over the past year.

During the September ACIP meeting, several new panel members expressed skepticism of vaccines and dismissed evidence — including the CDC’s own data — demonstrating that they are safe and effective.

That included Kulldorff’s questions and remarks about covid vaccines and birth defects.

In a Pfizer clinical trial, hundreds of pregnant women were given covid vaccines or a placebo during the second and third trimesters of pregnancy. But the birth defects Pfizer reported in its clinical study typically would have formed long before the vaccine was given, said Jeffrey Morris, a biostatistics and public health professor at the University of Pennsylvania Perelman School of Medicine.

“To say that this is a major safety risk,” Morris said, “is beyond a stretch.”

“This one really upsets me because it’s just so misleading,” he said.

Multiple large studies have shown no association between covid vaccines and miscarriage, stillbirth, or birth defects.

In response to questions for this article, Kulldorff said: “In the randomized trial, there were four times as many birth defects in children born to mothers receiving the Pfizer covid vaccine during pregnancy compared to the placebo-receiving control group. To ensure vaccine confidence, it is the responsibility of ACIP to note and inquire about such discrepancies, and it is the manufacturer’s responsibility to thoroughly examine it through additional follow-up studies.”

Kulldorff said he is “not affiliated with the Brownstone Institute” but declined to respond to additional questions, including whether he is currently compensated by the organization or has donated to it. The Brownstone Institute paid Kulldorff $108,333 in 2022, according to tax filings.

Levi said he heard about the Brownstone Institute from social media. He said he is in contact with Tucker “once in a while” but said Tucker has not advised him on vaccines since he was named to the CDC’s vaccine panel. Levi said he has “never received any compensation,” “never had any affiliation,” and “never donated or given any money” to the group.

Bhattacharya did not respond to questions. Williams, the NIH spokesperson, who had earlier declined to respond, citing the federal government shutdown, did not respond to a query seeking comment after the shutdown ended Nov. 12.

Stein declined to comment and referred questions to HHS. Department spokesperson Andrew Nixon said in a statement that Stein’s ACIP appointment “reflects the Administration’s commitment to independent, evidence-based science. Her professional record speaks for itself.”

The Brownstone Institute’s website says it works “to support writers, lawyers, scientists, economists, and other people of courage who have been professionally purged and displaced during the upheaval of our times.”

“There’s a danger associated with a state-imposed orthodoxy,” Tucker said in the interview. “I think Brownstone has a moral obligation to care for dissidents and create settings in which they’re able to test their ideas against people with whom they disagree.”

He said that “there’s never harm that comes from open debate and open distribution of information and views.” But Brownstone’s critics say its associates make extreme claims about vaccines and promote anti-vaccine messages.

“They kind of position themselves as defending freedom, but they consistently platform covid minimizers and vaccine skeptics,” Scott said.

Tucker took issue with the description, saying “it presumes that we know exactly with scientific precision the severity of covid, and so anybody who falls short of explaining that with amazing precision is a minimizer.”

Jeffrey Tucker was a speaker at the National Conservatism conference on Sept. 2 in Washington.(Dominic Gwinn/Middle East Images via AFP/Getty Images)

In early September, Scott testified at a Senate subcommittee hearing on vaccines alongside Toby Rogers, a political economist and Brownstone Institute fellow who doesn’t list any medical credentials. Rogers wrote last year in his Substack newsletter that “vaccines are a civilization-destroying technology” and has promoted the debunked idea that vaccines cause autism. “My belief is that the autism and chronic disease epidemics are primarily caused by toxicants — mostly from vaccines and about a dozen additional toxicants,” Rogers said at the Senate hearing. Numerous studies have shown there is no link between vaccines and autism.

Days later, members of Kennedy’s handpicked panel of CDC vaccine advisers “spent hours elevating these theories” about vaccines “that are not really based in solid evidence or high-quality studies,” Scott said. “They manufactured doubt about established vaccines, entertained all this speculation without any evidence — that’s the real damage.”

Levi, responding to that criticism, said: “For the first time in a long time we are issuing objective, evidence-based immunization recommendations through ACIP with honest and transparent discussion of the benefits, risks, and uncertainties.”

As the panel weighed whether to delay the hepatitis B shot given to most newborns, Høeg, a senior adviser for clinical sciences at the FDA, questioned whether the vaccine is safe. “We should have some humility and consider that we may not know all of the potential safety issues,” she said to the CDC panel.

Widespread evidence shows that the hepatitis B newborn dose is safe and that the shot has very few side effects. Starting in 1991, the CDC recommended that the first of three shots of hepatitis B vaccine be given to infants shortly after birth. The move virtually eliminated the potentially fatal disease among American children. Babies infected with the virus at birth have a 90% chance of developing chronic hepatitis B.

In academic journals, Høeg has disclosed receiving payment from the Brownstone Institute but did not specify the amount. She has described Tucker as “a good friend.” Høeg did not respond to a request for comment for this article.

In an email, the FDA’s Prasad said that he “has received no money from Brownstone or any person(s) affiliated” and that all his content published on its website “was republished from his own personal Substack.”

Tucker said he has not advised Prasad or Høeg on vaccines since they became FDA officials. He described the latest CDC vaccine panel meeting as “a breath of fresh air.”

The Covid Contrarian Clubhouse

The Brownstone Institute, on its website, previously called itself “the spiritual child of the Great Barrington Declaration,” the controversial pandemic treatise Bhattacharya, Kulldorff, and Oxford University epidemiologist Sunetra Gupta co-authored in October 2020 that argued against lockdown measures to prevent the covid virus from spreading.

They proposed that widespread immunity against covid could be achieved by allowing healthy people to get infected, known as herd immunity, with protective measures instituted for medically vulnerable people.

The proposal was criticized at the time by many public health experts and high-ranking government officials, including then-NIH Director Francis Collins, who called its authors “fringe epidemiologists,” according to emails the American Institute for Economic Research obtained through a Freedom of Information Act request. (Tucker was AIER editorial director from 2017 to 2021.)

“They’ve been willing to publish articles of some very extreme anti-vaccine people,” Dorit Reiss, a professor at University of California Law-San Francisco focused on vaccine-related legal and policy issues, said of the Brownstone Institute. “They’re trying to give a more respectable veneer to the result of the Great Barrington Declaration,” she added.

In response, Tucker said: “I don’t think being an extremist is a good basis on which to shut somebody’s thoughts down. We need provocations.”

Tucker said he did not propose that Bhattacharya — who was a senior scholar at the institute and wrote 29 articles from July 2021 through October 2024 — be nominated to lead the NIH. More than one-third of the articles were co-authored with Kulldorff, who became Brownstone’s senior scientific director in November 2021.

Kulldorff told National Review he was fired from the Harvard-affiliated Mass General Brigham hospital system and placed on leave at the university that month after he refused to be vaccinated against covid, saying he had natural immunity. Kulldorff said he was hospitalized for a covid infection in early 2021.

The Brownstone Institute reported nearly $7.4 million in contributions, grants, and other payments between 2021 and 2024, with about 35% coming from tax-exempt foundations and donor-advised funds, according to an analysis of tax filings. Donor-advised funds allow people to secure tax deductions for anonymous charitable contributions. Tucker said the organization has 17,000 donors, most of them small, but declined to elaborate on funders.

The filings show the institute has also received funding from foundations run by people with backgrounds in business, including in tech, finance, law, and banking. According to a review of tax records, many of them have also given to anti-vaccine organizations; groups such as the Independent Medical Alliance, which promoted ineffective treatments for covid; or prominent organizations in conservative politics, such as the Federalist Society, the Alliance Defending Freedom, and the Heritage Foundation. Brownstone in 2023 received $67,350 from Donors Trust Inc., which funds conservative causes.

As of 2024, the Brownstone Institute’s board included David Stockman, a White House budget chief under President Ronald Reagan; libertarian economist Donald Boudreaux; and Roger Ver, an investor known as “Bitcoin Jesus.”

Ver’s website said he gave more than $1 million to the institute.

In 2024, Ver was indicted by a federal grand jury for allegedly committing tax fraud costing the IRS at least $48 million. On Oct. 14, the Justice Department announced that Ver had entered into a deferred prosecution agreement to resolve federal tax charges against him and has paid the IRS nearly $50 million. The government has moved to dismiss the indictment against him.

‘People Are Very Skeptical’

Other than publishing posts on its website, the institute awards fellowships and convenes conferences and retreats. Its associates testify in front of Congress. And it holds a “Supper Club” series in cities throughout the country.

“The goal of Brownstone is to make possible wide-ranging conversations about the failure of the system and the solutions to it,” Tucker said.

Ashley Grogg, a registered nurse and founder of Hoosiers for Medical Liberty, spoke at a Supper Club in August on “informed decision-making,” primarily about vaccines.

“People are very skeptical,” Grogg said in an interview. “How do we trust people moving forward? Do we really think that we can trust the new leadership that’s coming in to do the right thing?”

She said she was connected to Brownstone through one of her members. Grogg said she does not think newborns should universally be given the hepatitis B vaccine shortly after birth and opposes vaccine mandates. “I don’t want to take anything away from anybody,” but people who refuse to be vaccinated should not be “withheld from society,” Grogg said.

In September, as the CDC’s vaccine advisers met, Tucker took to the social media platform X to amplify statements questioning vaccines, including from panel members with ties to the group he created. One was Malone saying, “It’s clear that a significant population in the United States has significant concerns about vaccine policy and about vaccine mandates.” Another was from Levi, who, referring to covid vaccines, said, “Most of us are extremely concerned about the safety and the lack of robust evidence both on safety and efficacy for not only pregnant women, but their babies.”

There is strong evidence that mRNA and non-mRNA covid vaccines are safe for pregnant women. A mother’s vaccination while pregnant also helps protect newborns. CDC data that drew upon medical records in 12 states found that nearly 90% of babies who were hospitalized with covid had mothers who did not get the vaccine while pregnant.

In response to questions for this article, Levi said in an email that “the claim that there is strong evidence for the efficacy and safety of covid vaccination during pregnancy in the absence of appropriate clinical trials is not consistent with fundamental regulatory principles” and that panel members “were also concerned by the potential safety signal in the single (small) clinical trial that was conducted, and other research.” Malone did not respond to questions for this article.

Kulldorff, the ACIP chair, said the panel will review vaccines given during pregnancy, childhood, and adolescence.

Less than a week after the ACIP meeting in Atlanta, Levi gave a Brownstone Institute talk about artificial intelligence systems.

Brownstone was a sponsor this month when Children’s Health Defense, a leading anti-vaccine nonprofit founded by Kennedy, held its annual conference in Austin.

And during the institute’s own annual conference recently in Utah, Bhattacharya was one of three people who received its first “Brownstone Prize.”

“I would think it represents a kind of integrity and courage in public life,” Tucker said, “and stand up for what you believe is the truth, even at some degree of personal risk.”



Source link